Loading resource…

Dr Agaba Gidio
This document reviews the role of SGLT‑2 inhibitors in treating type 2 diabetes, covering pathophysiology, diagnostic criteria, glycemic targets, non‑insulin agents, and guideline recommendations.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

PassMedicine endocrine 2025 -part 2
Same clinical topic · Endocrinology

CURBING UNNECESSARY VITAMIN D TESTING
Same clinical topic · Endocrinology

The Role of SGLT-2 Inhibitors in the Management of Patients with Type 2 Diabetes
Same clinical topic · Endocrinology

Uganda Diabetes Management Guidelines – Summarised (2026)
Same specialty · Endocrinology

Kiruddu DKA guidelines
Same specialty · Endocrinology

DIABETES MELLITUS
Same specialty · Endocrinology

Pharmacotherapy for Obesity Management: 2025 Guidelines
Same specialty · Endocrinology

Management of DKA
Same specialty · Endocrinology

ADA Consensus Report: MASLD in People With Diabetes
Same specialty · Endocrinology